Curis, Inc. (CRIS) vs PMGC Holdings Inc. (ELAB)
A side-by-side comparison of Curis, Inc. and PMGC Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRIS
Curis, Inc.
$0.75HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT
ELAB
PMGC Holdings Inc.
$3.27HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
Total return — CRIS vs ELAB
growth of $100 · dividends reinvested · last 3yCRIS -99.3% (-80.6%/yr)ELAB -100.0% (-99.4%/yr)CRIS compounded faster over this window
Log scale — wide-divergence pair
CRIS ELAB
CRIS vs ELAB: by the numbers
- •ELAB is the larger company ($1M vs $1M market cap).
- •Both run net losses; CRIS's is the smaller (-490.33% vs -522.97% net margin).
Metrics side by side
Valuation
| Metric | CRIS | ELAB |
|---|---|---|
| P/S ratio | 0.34 | 0.58 |
| P/B ratio | 0.31 | 0.09 |
Profitability
| Metric | CRIS | ELAB |
|---|---|---|
| Gross margin | 99.28% | 10.31% |
| Operating margin | -348.43% | -1250.11% |
| Net margin | -490.33% | -522.97% |
| ROE | -450.54% | -80.57% |
| ROIC | -567.17% | N/A |
Growth (annualized)
| Metric | CRIS | ELAB |
|---|---|---|
| Revenue CAGR (5Y) | -15.88% | N/A |
| Total return CAGR (5Y) | -81.06% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.